VECORIS Trademark

Trademark Overview

On Friday, April 27, 2007, a trademark application was filed for VECORIS with the United States Patent and Trademark Office. The USPTO has given the VECORIS trademark a serial number of 77167430. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 24, 2017. This trademark is owned by sanofi-aventis. The VECORIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical product for the prevention and/or the treatment of cancer
vecoris

General Information

Serial Number77167430
Word MarkVECORIS
Filing DateFriday, April 27, 2007
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 24, 2017
Registration Number3820051
Registration DateTuesday, July 20, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 9, 2010

Trademark Statements

Goods and ServicesPharmaceutical product for the prevention and/or the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 24, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSANOFI
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressParis 75008
FR
Party Namesanofi-aventis
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address75013 Paris
FR
Party Namesanofi-aventis
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address75013 Paris
FR
Party Namesanofi-aventis
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address75013 Paris
FR

Trademark Events

Event DateEvent Description
Friday, February 24, 2017CANCELLED SEC. 8 (6-YR)
Thursday, March 31, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 7, 2012APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 7, 2012TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 1, 2011AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 20, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, February 9, 2010PUBLISHED FOR OPPOSITION
Wednesday, January 20, 2010NOTICE OF PUBLICATION
Thursday, January 7, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 7, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 14, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 14, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 9, 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, September 24, 2009REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, March 24, 2009REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, March 24, 2009ASSIGNED TO LIE
Wednesday, September 24, 2008REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, September 24, 2008ASSIGNED TO LIE
Monday, March 24, 2008LETTER OF SUSPENSION MAILED
Monday, March 24, 2008SUSPENSION LETTER WRITTEN
Wednesday, March 5, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 5, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 5, 2008TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, February 4, 2008LETTER OF SUSPENSION MAILED
Monday, February 4, 2008SUSPENSION LETTER WRITTEN
Thursday, January 3, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 3, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 3, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 5, 2007NON-FINAL ACTION MAILED
Wednesday, July 4, 2007NON-FINAL ACTION WRITTEN
Tuesday, June 26, 2007ASSIGNED TO EXAMINER
Tuesday, May 1, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

vecoris cancer treatment prevention product pharmaceutical